Investor relations at Farbe Firma

Building long-term value through transparency, governance and sustainable growth in sterile injectable manufacturing.

Investor Relations

Governance, growth and infrastructure

At Farbe Firma Pvt. Ltd., we are committed to building long-term value through transparency, compliance and sustainable growth, continuously investing in infrastructure, regulatory approvals and global partnerships.

Our registration under the International Securities Identification Number (ISIN: INE0KRZ01010) reflects our commitment to global standards and enables seamless tracking of our shares. Farbe Firma also holds an LEI (Legal Entity Identifier), an internationally recognised standard supported by G20 countries.

With exports to more than 30 countries and high-speed production lines, we are positioned to expand further and capture emerging market opportunities — creating value for patients, partners and investors.

Highlights

At a glance

ISIN registered

INE0KRZ01010 — for seamless global share tracking.

LEI certified

An internationally recognised, G20-supported entity identifier.

WHO-GMP compliant

Sterile injectable manufacturing to international standards.

Global presence

Exports to 30+ countries across Asia, Africa, CIS and Latin America.

High-speed production

Ampoule, vial and lyophilized lines with automation.

Sustainable growth

Transparent governance and responsible business practices.

FAQ

Investor questions

For investor enquiries, write to director@farbefirma.org.

Is Farbe Firma compliant with global regulatory standards (WHO-GMP, LEI, ISIN)?

Yes. We operate WHO-GMP compliant facilities for sterile injectables and hold an LEI (Legal Entity Identifier), a G20-recognised standard for transparency. Our ISIN (INE0KRZ01010) registration supports global share tracking and corporate governance compliance.

What are Farbe Firma’s manufacturing capabilities in the sterile injectable sector?

We specialise in high-barrier-to-entry formulations, with high-speed production lines for ampoules, vials and lyophilized (freeze-dried) injectables — positioning us as a CDMO partner in the critical-care segment.

Which international markets does Farbe Firma currently serve?

We export to over 30 countries across Asia, Africa, the CIS and Latin America, and are expanding into high-growth emerging pharmaceutical markets.

Does Farbe Firma offer Contract Manufacturing (CDMO) services?

Yes. We offer end-to-end CDMO solutions for global partners, from formulation to sterile filling.